Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

When people think of kidney disease, they usually think about problems with how the body removes waste—not about skin issues.

Among 200 dialysis patients, 37% were non-compliant with their phosphate binders compared with 12% to 18% of patients who ...

Hydration is another critical factor in managing CKD. Encouraging water intake through the use of hydration-friendly diets, water fountains, and owner-administered subcutaneous fluid therapy can help ...

Patients on kidney dialysis reported better adherence to an investigational phosphate-binding agent designed to be smaller, ...

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant ...

(Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today ...

Unicycive Therapeutics (UNCY) announced new patient-reported outcomes data from its pivotal Phase 2 study of OLC as well as from a new survey ...

on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH offers a different mechanism ...

LOS ALTOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease ...

A kidney transplant patient has died in Ohio after receiving an organ infected with rabies. The recipient received care in Lucas County, Ohio, in December 2024, the Toledo-Lucas County Health ...

Health care professionals should monitor closely for patient recovery, adjusting dialysis dose and frequency as appropriate. Care teams should also offer prognosis discussions to inform and ...